Mammalian X and Y chromosomes evolved from an ordinary autosomal pair; genetic 23 decay decimated the Y, which in turn necessitated X chromosome inactivation (XCI). 24
Genes of the ancestral autosomes are often assumed to have undertaken these transitions 25 on uniform terms, but we hypothesized that they varied in their dosage constraints. We 26 
INTRODUCTION 36
The mammalian X and Y chromosomes evolved from a pair of ordinary autosomes over the past 37 300 million years (Lahn & Page, 1999) . Only 3% of genes on the ancestral pair of autosomes 38 First, through genome-wide analysis of human copy number variation, we refined and 83 validated a method for inferring dosage sensitivity based on patterns of conserved miRNA 84 targeting. Using this tool, we inferred heterogeneities in dosage sensitivity between the three 85 classes of X-linked genes and the two classes of Z-linked genes. We then demonstrated that these 86 differences were likely to have been present on the ancestral autosomes that gave rise to the 87 mammalian and avian sex chromosomes. Finally, we used publically available experimental 88 datasets to validate the efficacy, in living cells, of the conserved miRNA targeting. These 89 findings have important implications for our understanding of X and Z dosage compensation, 90 and provide the foundation for a model of X-Y and Z-W evolution in which both survival on the 91 sex-specific Y or W chromosome and the subsequent evolution of XCI in mammals were 92 determined by preexisting sensitivities to under-and overexpression. 93
94

RESULTS
95
Analysis of human copy number variation indicates conserved microRNA targeting of 96
dosage-sensitive genes 97
We first sought to determine whether conserved targeting by microRNAs (miRNAs) correlates 98 with dosage sensitivity across the human genome. To estimate pressure to maintain miRNA 99 targeting, we used published probabilities of conserved targeting (P CT scores) for each gene-100 miRNA interaction in the human genome. Since the P CT score intrinsically controls for 101 differences in the background conservation and sequence composition of individual 3'UTRs, it is 102 comparable across both genes and miRNA families (Friedman et al., 2009). We refer to these 103 P CT scores as "miRNA conservation scores" in the remainder of the text. 104
Genes for which increases in dosage are deleterious should be depleted from the set of 105 observed gene duplications in healthy human individuals. We used a catalogue of rare genic 106 copy number variation among 59,898 control human exomes (Exome Aggregation Consortium, 107 ExAC) (Ruderfer et al., 2016) to classify autosomal protein-coding genes as exhibiting or lacking 108 duplication or deletion in healthy individuals (see Methods). We compared duplicated and non-109 duplicated genes with the same deletion status in order to control for differences in sensitivity to 110 underexpression. We found that non-duplicated genes have significantly higher miRNA 111 conservation scores than duplicated genes, irrespective of deletion status ( Figure 1A ,B). Non-112 deleted genes also have significantly higher scores than deleted genes irrespective of duplication 113 status (Figure 1 -figure supplement 1 ), but duplication status has a greater effect on miRNA 114 conservation scores than does deletion status (Figure 1 -figure supplement 2) We next assessed whether the three classes of X-linked genes differ with respect to dosage 132 sensitivity as inferred by conserved miRNA targeting. To delineate these classes, we began with 133 the set of ancestral genes reconstructed through cross-species comparisons of the human X 134 We next asked whether the differences in miRNA targeting for the three classes of X-linked 172 genes were present on the ancestral autosomes that gave rise to the mammalian X and Y 173 chromosomes. We focused on miRNA target sites in the 3' UTR of human orthologs that align 174 with perfect identity to a site in the chicken genome; these sites were likely present in the 175 common ancestor of mammals and birds and thus likely present on the ancestral autosomes. We 176 found that X-Y pairs have the highest fraction of genes with at least one human-chicken-177 conserved target site, followed by X-inactivated genes, and then X escape genes, with similar 178 results for the expanded set of X-Y pairs across 8 mammals ( Figure 3A,B) . We observed the 179 same pattern after accounting for the background conservation of each individual 3' UTR (see 180
Methods) (Figure 3 -figure supplement 1) . These results indicate that the autosomal precursors 181 of X-Y pairs and X-inactivated genes were more dosage-sensitive than those of X escape genes; 182 present-day heterogeneities in dosage sensitivity on the mammalian X chromosome were present 183 on the ancestral autosomes from which it derived. We next asked whether the differences in miRNA targeting between Z-W pairs and other 236 ancestral Z-linked genes were present on the ancestral autosomes that gave rise to the avian Z 237 and W chromosomes. We found that both chicken Z-W pairs and the predicted 4-and 14-species 238 
DISCUSSION 288
Here, through phylogenetic and functional analysis of conserved microRNA (miRNA) targeting, 289
we demonstrate preexisting heterogeneities in dosage sensitivity among genes on the mammalian 290 X and avian Z chromosomes. We first showed that, across all human autosomal genes, dosage 291 sensitivity --as indicated by patterns of genic copy number variation --correlates with the degree 292 of conserved miRNA targeting. Turning to the sex chromosomes of mammals and birds, genes 293 that retained a homolog on the sex-specific Y or W chromosome (X-Y and Z-W pairs) are more 294 dosage-sensitive than genes with no Y or W homolog. In mammals, genes with no Y homolog 295 that became subject to XCI are more dosage-sensitive than those that continued to escape XCI 296 following Y gene decay. These differences in dosage sensitivity were present on the ancestral 297 autosomes that gave rise to the mammalian and avian sex chromosomes. Finally, through 298 analysis of publically available experimental datasets, we validated the efficacy, in living cells, 299 of the miRNA target sites used to infer dosage sensitivity. We thus conclude that differences in 300 dosage sensitivity among genes on the ancestral autosomes influenced their evolutionary 301 trajectory during sex chromosome evolution, not only on the sex-specific Y and W chromosomes, 302 but also on the sex-shared X chromosome. 303
We and others previously proposed that Y gene decay drove upregulation of homologous 304 X-linked genes in both males and females, and that XCI subsequently evolved at genes sensitive 305 to increased expression from two active X-linked copies in females (Jegalian & Page, 1998 ; 306
Ohno, 1967). Our finding that X-inactivated genes have higher miRNA conservation scores than 307 X escape genes is consistent with this model. However, our finding of heterogeneities in dosage 308 sensitivity among the ancestral, autosomal precursors of both mammalian X-linked and avian Z-309 linked genes challenges the previous assumption of a single evolutionary pathway for all sex-310 linked genes. 311
We therefore propose a model of X-Y and Z-W evolution in which the ancestral 312 autosomes that gave rise to the mammalian and avian sex chromosomes contained three (or two, 313 in the case of birds) classes of genes with differing dosage sensitivities ( Figure 7A,B Recent work has revealed that the sex-specific chromosome --the Y in mammals and the 389 W in birds --convergently retained dosage-sensitive genes with important regulatory functions 390 (Bellott et al., 2014, 2017). Our study provides direct evidence that such heterogeneity in dosage 391 sensitivity existed on the ancestral autosomes that gave rise to the mammalian and avian sex 392 chromosomes. This heterogeneity influenced both survival on the sex-specific chromosomes in 393 mammals and birds and the evolution of XCI in mammals. Thus, two independent experiments 394 of nature have shown that modern-day amniote sex chromosomes were shaped, during evolution, 395 by the properties of the ancestral autosomes from which they derive. 396
METHODS 397
Human genic copy number variation 398
To annotate gene deletions and duplications, we used data from the Exome Aggregation 399 Consortium (ExAC, RRID:SCR_004068) 400 (ftp://ftp.broadinstitute.org/pub/ExAC_release/release0.3.1/cnv/), which consists of autosomal 401 genic duplications and deletions (both full and partial) called in 59,898 exomes (Ruderfer et al., 402 2016). We used the publicly available genic deletion counts but re-computed genic duplication 403 counts using only full duplications, reasoning that partial duplications are unlikely to result in 404 increased dosage of the full gene product. We thus required that an individual duplication fully 405 overlapped the longest protein-coding transcript (GENCODE v19) of a gene using BEDtools 406 with replacement from the same group of genes and computed the mean gene-miRNA P CT score 454 for all associated gene miRNA interactions from each sampling. These 1000 samplings were 455 then used to estimate the median resampled gene-miRNA P CT and 95% confidence intervals. To 456 compare P CT scores between two sets of genes while matching by haploinsufficiency probability 457 (Huang et al., 2010) , we binned the smaller of the two gene sets into quintiles based on the 458 assigned haploinsufficiency probabilities. We then binned the second gene set based on these 459 same quintiles. For each of 1000 samplings, we randomly drew n genes from the second set from 460 each of the quintile bins, where n is the number of genes from the first set assigned to that 461 quintile. We computed a mean gene-miRNA P CT score from each randomly sampled gene set 462 and used this distribution to compute an empirical one-sided P-value. 463 464 465
Human-chicken conserved microRNA target sites 466
Site-wise alignment information was obtained from TargetScanHuman v7.1 467 (http://www.targetscan.org/vert_71/vert_71_data_download/Conserved_Family_Info.txt.zip). To 468 determine which target sites are present in the 3' UTRs of both human and chicken orthologs, we 469 counted, for genes with both a human and chicken ortholog, the number of miRNA interactions 470 that had at least one target site in both human and chicken. To control for gene-specific 471 background 3' UTR conservation, we generated six control k-mers for each miRNA family seed 472 sequence that were matched exactly for nucleotide and CpG content. Six was the maximum 473 number of unique control k-mers that could be generated for all sequences. We repeated the 474 above counting analysis with each of the control k-mers using scripts from TargetScan, and 475 compared, for each gene, the observed number of human-chicken-conserved miRNA interactions 476 
Data availability 496
Data supporting the findings of this study are available within the paper and its supplementary 497 information files. 498
499
Code availability 500
Custom scripts in R (RRID:SCR_001905) were used to generate figures. A custom Python 501 (RRID:SCR_008394) script utilizing Biopython (RRID:SCR_007173) was used to generate 502 shuffled miRNA family seed sequences; all code is available upon request from the authors. 503
Identification of miRNA target site matches using shuffled seed sequences was performed using 504 the 'targetscan_70.pl' perl script 505 were further stratified as deleted (blue, n = 3,976 genes; grey, n = 4,118 genes) or not deleted 704 (purple, n = 3,510 genes; orange, n = 2,916 genes). Points and error bars represent the median 705 and 95% confidence intervals of P CT scores from 1,000 gene samplings with replacement. * p < 706 0.05, *** p < 0.001, empirical p-value computed as the fraction of random non-overlapping gene 707 sets with a median difference in P CT score at least as large as the true difference. haploinsufficiency probability between X-linked genes. In each row, genes from the 720 "background" set (indicated in the third column) were matched to genes in the "foreground" set 721 (first column) by their predicted haploinsufficiency probability. The mean P CT score of the 722 foreground set was compared to the distribution of mean P CT scores from the matched 723 background set to obtain a one-sided empirical p-value. 724 haploinsufficiency probability between Z-linked genes. In each row, genes from the 756 "background" set (indicated in the third column) were matched to genes in the "foreground" set 757 (first column) by their predicted haploinsufficiency probability. The mean P CT score of the 758 foreground set was compared to the distribution of mean P CT scores from the matched 759 background set to obtain a one-sided empirical p-value. 
